London’s AIM Index has returned to its winning ways on, undeterred by Sterling’s continued march higher. The junior market closed up six points at 1189.88
- Jaywing Plc up 44%
- Premier African Minerals up 28%
- Comptoir Group up 15%
- Catenae Innovations down 22%
- I-Nexus Global down 13%
Media company JaywingLON:JWNG topped the board today, adding 44% by the close. There’s no news here but the gains follow a trend which has been in play since the start of the year. There has however been a definite uptick in the number of orders place in the stock today so will be worth watching if a statement emerges off the back of this. The spread remains comparatively tight for a thinly traded small cap.
Premier African Minerals LON:PREM also makes it back onto our list, but today as the second biggest gainer. There were some questions asked over the decision to start fundraising in the US earlier in the week, but today’s 28% step up reverses most of that downside, leaving the stock close to last week’s highs. No firm news to support the move however.
Catenae Innovations LON:CTEA is the biggest faller, off 22% on the day although the stock remains well ahead of where it finished last week. Recent speculation had been that the company may play a role in some kind of COVID certification app, but with reports now suggesting this will be bolted onto the existing NHS Test and Trace app, sentiment does appear to have turned.
I-Nexus Global LON:INX has been another big faller on the day, shedding 13%, but there’s little of note here. It’s a £2m market cap company trading on a wide spread and has picked up some gains in the last few days. Nothing to see here….
A notable mention for Comptoir Group LON:COM who made it onto the list yesterday after the restaurant chain found further confidence amongst investors having tacked on 15% during Wednesday’s session. Confidence that consumers will soon be back in restaurants is to be applauded and whilst the government appears to have got a lot better at managing expectations, it’s worth bearing in mind that we could still face headwinds in the COVID exit strategy.
